EP2163553A4 - Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof - Google Patents
Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereofInfo
- Publication number
- EP2163553A4 EP2163553A4 EP08772919A EP08772919A EP2163553A4 EP 2163553 A4 EP2163553 A4 EP 2163553A4 EP 08772919 A EP08772919 A EP 08772919A EP 08772919 A EP08772919 A EP 08772919A EP 2163553 A4 EP2163553 A4 EP 2163553A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- macroring
- arene
- polyamine
- derivatives
- preparation methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101060457A CN101314595B (en) | 2007-05-30 | 2007-05-30 | Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof |
PCT/CN2008/001070 WO2008148302A1 (en) | 2007-05-30 | 2008-05-30 | Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
EP2163553A1 EP2163553A1 (en) | 2010-03-17 |
EP2163553A4 true EP2163553A4 (en) | 2011-08-03 |
EP2163553B1 EP2163553B1 (en) | 2013-12-25 |
Family
ID=40093160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08772919.0A Not-in-force EP2163553B1 (en) | 2007-05-30 | 2008-05-30 | Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof |
Country Status (5)
Country | Link |
---|---|
US (1) | US8420626B2 (en) |
EP (1) | EP2163553B1 (en) |
CN (1) | CN101314595B (en) |
HK (1) | HK1138580A1 (en) |
WO (1) | WO2008148302A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2755966B1 (en) | 2011-09-13 | 2017-03-15 | Brookhaven Science Associates LLC | Bimetallic catalysts for co2 hydrogenation and h2 generation from formic acid and/or salts thereof |
CN102584732B (en) * | 2011-12-31 | 2014-04-30 | 江苏奥赛康药业股份有限公司 | Method for preparing plerixafor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3373077A (en) * | 1963-06-07 | 1968-03-12 | Monsanto Res Corp | Soluble and fusible, heat resistant, chelate polymers |
JP2853351B2 (en) * | 1990-11-07 | 1999-02-03 | 富士電機株式会社 | Electrophotographic photoreceptor |
WO2004014316A2 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
CA2495245A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
-
2007
- 2007-05-30 CN CN2007101060457A patent/CN101314595B/en not_active Expired - Fee Related
-
2008
- 2008-05-30 US US12/601,867 patent/US8420626B2/en not_active Expired - Fee Related
- 2008-05-30 EP EP08772919.0A patent/EP2163553B1/en not_active Not-in-force
- 2008-05-30 WO PCT/CN2008/001070 patent/WO2008148302A1/en active Application Filing
-
2010
- 2010-04-28 HK HK10104135.6A patent/HK1138580A1/en not_active IP Right Cessation
Non-Patent Citations (3)
Title |
---|
JING, SU ET AL: "Synthesis of aromatic-linked polyamine macrocyclic derivatives as HIV-1 entry inhibitors", CHINESE CHEMICAL LETTERS, vol. 18, 2007, pages 1166 - 1168, XP002644327, ISSN: 1001-8417 * |
See also references of WO2008148302A1 * |
WALLON, ALEXANDER ET AL: "Pentamacrocyclic tris-crown hosts: selective binding of cationic, anionic, and neutral guests", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS, vol. 123, 1990, pages 859 - 867, XP002644328, ISSN: 0022-4936 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008148302A1 (en) | 2008-12-11 |
US20100179116A1 (en) | 2010-07-15 |
CN101314595B (en) | 2011-04-20 |
EP2163553B1 (en) | 2013-12-25 |
HK1138580A1 (en) | 2010-08-27 |
EP2163553A1 (en) | 2010-03-17 |
US8420626B2 (en) | 2013-04-16 |
CN101314595A (en) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200808365B (en) | Dicyclooctane derivates, preparation processes and pharmaceutical uses thereof | |
HK1117164A1 (en) | Dicyclic azaalkane derivatives, preparing method and pharmaceutical use thereof | |
EP2124550A4 (en) | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | |
EP2157093A4 (en) | Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof | |
EP1990337A4 (en) | Quinazoline derivatives,preparation methods and uses thereof | |
IL200206A (en) | Quinoxaline derivatives, their preparation and pharmaceutical compositions containing them | |
IL195245A0 (en) | Substituted prolinamides, production thereof and their use as drugs | |
HK1161878A1 (en) | Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof | |
IL206808A (en) | Indolyl-pyridone derivatives, pharmaceutical compositions comprising the same and uses thereof | |
TWI372621B (en) | Water-soluble iron-carbohydrate derivative complexes, the preparation thereof, and medicaments comprising them | |
HK1159108A1 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
ZA201002307B (en) | Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof | |
PL1988090T3 (en) | Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof | |
EP2199402A4 (en) | Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof | |
SI2146991T1 (en) | Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof | |
EP2184277A4 (en) | Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof | |
ZA200900617B (en) | Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof | |
EP1911761A4 (en) | Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof | |
SI2448940T1 (en) | 6,7,8,9-tetrahydro-pyrimidoš1,2-ać pyrimidin-4-one derivatives, their preparation and pharmaceutical use thereof | |
EP2386553A4 (en) | Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses | |
IL193384A0 (en) | Substituted prolinamides, their preparation and their use as pharmaceuticals | |
EP2119720A4 (en) | Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives | |
PL2220047T3 (en) | Quinoline derivatives, pharmaceutical compositions comprising them, and use thereof | |
TWI366566B (en) | Tricyclic n-heteroarylcarboxamide derivatives, preparation thereof and therapeutic use thereof | |
HK1138580A1 (en) | Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091211 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1138580 Country of ref document: HK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20110706 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/395 20060101ALI20110627BHEP Ipc: A61P 31/18 20060101ALI20110627BHEP Ipc: C07D 409/14 20060101ALI20110627BHEP Ipc: C07D 403/14 20060101ALI20110627BHEP Ipc: C07D 403/06 20060101AFI20110627BHEP Ipc: A61K 31/4178 20060101ALI20110627BHEP Ipc: A61K 31/41 20060101ALI20110627BHEP Ipc: A61K 31/427 20060101ALI20110627BHEP Ipc: A61K 31/559 20060101ALI20110627BHEP Ipc: C07D 401/14 20060101ALI20110627BHEP Ipc: A61K 31/4155 20060101ALI20110627BHEP Ipc: A61K 31/435 20060101ALI20110627BHEP Ipc: C07D 417/14 20060101ALI20110627BHEP Ipc: C07D 405/14 20060101ALI20110627BHEP |
|
17Q | First examination report despatched |
Effective date: 20120307 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130715 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 646580 Country of ref document: AT Kind code of ref document: T Effective date: 20140115 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602008029533 Country of ref document: DE Effective date: 20140213 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1138580 Country of ref document: HK |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140325 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20131225 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 646580 Country of ref document: AT Kind code of ref document: T Effective date: 20131225 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140425 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140428 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602008029533 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140926 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140530 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602008029533 Country of ref document: DE Effective date: 20140926 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140326 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131225 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20080530 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20190514 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20190527 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20190529 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602008029533 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200530 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201201 |